Elekta AB EPS - Earnings per Share 2013-2025 | EKTAY
Elekta AB eps - earnings per share from 2013 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Elekta AB Annual EPS | |
|---|---|
| 2024 | $0.32 |
| 2023 | $0.24 |
| 2022 | $0.34 |
| 2021 | $0.38 |
| 2020 | $0.30 |
| 2019 | $0.35 |
| 2018 | $0.35 |
| 2017 | $0.04 |
| 2016 | $0.04 |
| 2015 | $0.20 |
| 2014 | $0.44 |
| 2013 | $0.53 |
| 2012 | $1.96 |
| Elekta AB Quarterly EPS | |
|---|---|
| 2025-01-31 | $0.08 |
| 2024-10-31 | $0.05 |
| 2024-07-31 | $0.02 |
| 2024-04-30 | $0.10 |
| 2024-01-31 | $0.08 |
| 2023-10-31 | $0.08 |
| 2023-07-31 | $0.06 |
| 2023-04-30 | $0.14 |
| 2023-01-31 | $0.05 |
| 2022-10-31 | $0.03 |
| 2022-07-31 | $0.02 |
| 2022-04-30 | $0.12 |
| 2022-01-31 | $0.07 |
| 2021-10-31 | $0.12 |
| 2021-07-31 | $0.04 |
| 2021-04-30 | $0.10 |
| 2021-01-31 | $0.10 |
| 2020-10-31 | $0.11 |
| 2020-07-31 | $0.06 |
| 2020-04-30 | $0.11 |
| 2020-01-31 | $0.09 |
| 2019-10-31 | $0.06 |
| 2019-07-31 | $0.04 |
| 2019-04-30 | $0.16 |
| 2019-01-31 | $0.06 |
| 2018-10-31 | $0.08 |
| 2018-07-31 | $0.05 |
| 2018-04-30 | $0.17 |
| 2018-01-31 | $0.10 |
| 2017-10-31 | $0.08 |
| 2017-07-31 | $0.00 |
| 2017-04-30 | $0.03 |
| 2017-01-31 | $0.01 |
| 2016-10-31 | $0.02 |
| 2016-07-31 | $-0.02 |
| 2016-04-30 | $0.02 |
| 2016-01-31 | $0.00 |
| 2015-10-31 | $0.06 |
| 2015-07-31 | $-0.04 |
| 2015-04-30 | $0.11 |
| 2015-01-31 | $0.05 |
| 2014-10-31 | $0.07 |
| 2014-07-31 | $-0.05 |
| 2014-04-30 | $0.31 |
| 2014-01-31 | $0.06 |
| 2013-10-31 | $0.07 |
| 2013-07-31 | $0.00 |
| 2013-04-30 | $0.34 |
| 2013-01-31 | $0.09 |
| 2012-10-31 | $0.10 |
| 2012-07-31 | $0.00 |
| 2012-04-30 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $1.949B | $1.704B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||